USA - NASDAQ:AIMD - US00902F4028 - Common Stock
The current stock price of AIMD is 3.395 USD. In the past month the price decreased by -1.88%. In the past year, price increased by 46.02%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABBV | ABBVIE INC | 20.55 | 384.42B | ||
AMGN | AMGEN INC | 12.58 | 147.73B | ||
GILD | GILEAD SCIENCES INC | 14.54 | 139.64B | ||
VRTX | VERTEX PHARMACEUTICALS INC | 23.21 | 100.82B | ||
REGN | REGENERON PHARMACEUTICALS | 12.55 | 60.69B | ||
ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 60.45B | ||
ARGX | ARGENX SE - ADR | 81.64 | 46.32B | ||
ONC | BEONE MEDICINES LTD-ADR | 5.81 | 39.50B | ||
INSM | INSMED INC | N/A | 30.26B | ||
NTRA | NATERA INC | N/A | 23.63B | ||
BNTX | BIONTECH SE-ADR | N/A | 23.53B | ||
BIIB | BIOGEN INC | 8.95 | 21.01B |
Ainos, Inc. is a diversified medtech company, which engages in the development of medical technologies for point-of-care testing and safe and novel medical treatment for a broad range of disease indications. The company is headquartered in San Diego, California and currently employs 44 full-time employees. Its AI Nose platform and smell language model (SML) digitize scent into Smell ID, a machine-readable data, powering applications across robotics, smart factories, and healthcare. The company is also developing VELDONA, an oral low-dose interferon therapy targeting rare diseases, autoimmune diseases, infectious diseases, and animal health. Its pipeline includes drug candidates for treating oral warts for human immunodeficiency virus seropositive patients, Sjogren’s syndrome, and feline chronic gingivostomatitis, a cat oral infection. Its product pipeline includes VELDONA Pet, VELDONA human drugs, AI Nose - NISD co-development, AI Nose industrial and robotics application, VOC POCT, VOC POCT Ainos Pen, VOC POCT CHS430, and Synthetic RNA (SRNA). VOC POCT-Ainos Pen is a device intended to be a cloud-connected, multipurpose, portable breath analyzer that is intended to monitor health conditions.
AINOS INC
8880 Rio San Diego Drive, Ste. 800
San Diego CALIFORNIA US
Employees: 44
Phone: 18588692986
The current stock price of AIMD is 3.395 USD. The price decreased by -4.63% in the last trading session.
The exchange symbol of AINOS INC is AIMD and it is listed on the Nasdaq exchange.
AIMD stock is listed on the Nasdaq exchange.
AINOS INC (AIMD) has a market capitalization of 16.16M USD. This makes AIMD a Nano Cap stock.
AINOS INC (AIMD) currently has 44 employees.
AINOS INC (AIMD) has a support level at 3.39 and a resistance level at 3.55. Check the full technical report for a detailed analysis of AIMD support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
AIMD does not pay a dividend.
AINOS INC (AIMD) will report earnings on 2025-11-04.
AINOS INC (AIMD) does not have a PE ratio as the earnings reported over the last twelve months were negative (-5.27).
The outstanding short interest for AINOS INC (AIMD) is 6.41% of its float. Check the ownership tab for more information on the AIMD short interest.
ChartMill assigns a technical rating of 8 / 10 to AIMD. When comparing the yearly performance of all stocks, AIMD is one of the better performing stocks in the market, outperforming 88.74% of all stocks.
ChartMill assigns a fundamental rating of 1 / 10 to AIMD. AIMD has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months AIMD reported a non-GAAP Earnings per Share(EPS) of -5.27. The EPS increased by 66.76% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -65.73% | ||
ROE | -137.42% | ||
Debt/Equity | 0.96 |